US Stock MarketDetailed Quotes
SAVA Cassava Sciences
- 26.480
- -5.700-17.71%
Close Nov 22 16:00 ET
- 26.650
- +0.170+0.64%
Post 20:02 ET
1.27BMarket Cap-19188P/E (TTM)
31.400High26.020Low7.44MVolume31.360Open32.180Pre Close204.75MTurnover17.33%Turnover RatioLossP/E (Static)48.11MShares42.20052wk High7.64P/B1.14BFloat Cap8.79052wk Low--Dividend TTM42.93MShs Float146.160Historical High--Div YieldTTM16.72%Amplitude1.000Historical Low27.526Avg Price1Lot Size
About Cassava Sciences Company
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Company Profile
SymbolSAVA
Company NameCassava Sciences
Listing DateJul 14, 2000
Issue Price12.00
Founded1998
CEOMr. Richard J. Barry
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address6801 North Capital of Texas Highway,Suite 300
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78731
Phone1-512-501-2444
Company Executives
- Name
- Position
- Salary
- Richard J. Barry
- Chief Executive Officer
- 546.16K
- Eric Schoen
- Chief Financial Officer
- 2.99M
- Dr. James W. Kupiec, M.D.
- Chief Medical Officer
- 2.97M
- R. Christopher Cook
- Senior Vice President and General Counsel
- 1.27M
- Dr. Claude Nicaise,M.D.
- Chairman of the Board
- 474.50K
- Sanford R. Robertson
- Lead Independent Director
- 546.16K
- Dr. Patrick J. Scannon,M.D.,PhD
- Independent Director
- 438.42K
- Robert Anderson, Jr
- Independent Director
- 474.50K
- Pierre Gravier
- Independent Director
- 474.50K
- Michael J. O'Donnell, Esq.
- Independent Director
- 438.42K
- Dr. Robert Z. Gussin, PhD
- Independent Director
- 546.16K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
